112 related articles for article (PubMed ID: 8223415)
1. Acute and chronic anticonvulsant effects of D(-)CPPene in genetically epilepsy-prone rats.
Smith SE; Chapman AG
Epilepsy Res; 1993 Jul; 15(3):193-9. PubMed ID: 8223415
[TBL] [Abstract][Full Text] [Related]
2. Anticonvulsant properties of non-competitive antagonists of the N-methyl-D-aspartate receptor in genetically epilepsy-prone rats: comparison with CPPene.
De Sarro GB; De Sarro A
Neuropharmacology; 1993 Jan; 32(1):51-8. PubMed ID: 8094234
[TBL] [Abstract][Full Text] [Related]
3. Anticonvulsant activity of competitive antagonists of NMDA receptor in genetically epilepsy-prone rats.
De Sarro G; De Sarro A
Eur J Pharmacol; 1992 May; 215(2-3):221-9. PubMed ID: 1396987
[TBL] [Abstract][Full Text] [Related]
4. Lack of development of tolerance to anticonvulsant effects of two excitatory amino acid antagonists, CGP [corrected] 37849 and CGP 39551 in genetically epilepsy-prone rats.
De Sarro G; De Sarro A; Ammendola D; Patel S
Brain Res; 1996 Sep; 734(1-2):91-7. PubMed ID: 8896813
[TBL] [Abstract][Full Text] [Related]
5. Contrasting effects of D- and L-(E)-4-(3-phosphono-2-propenyl)piperazine-2-carboxylic acid as anticonvulsants and as inhibitors of potassium-evoked increases in hippocampal extracellular glutamate and aspartate levels in freely moving rats.
Millan MH; Chapman AG; Meldrum BS
J Neurochem; 1994 Jan; 62(1):217-22. PubMed ID: 7903351
[TBL] [Abstract][Full Text] [Related]
6. Effects of 7-nitroindazole, NG-nitro-L-arginine, and D-CPPene on harmaline-induced postural tremor, N-methyl-D-aspartate-induced seizures, and lisuride-induced rotations in rats with nigral 6-hydroxydopamine lesions.
Eblen F; Löschmann PA; Wüllner U; Turski L; Klockgether T
Eur J Pharmacol; 1996 Mar; 299(1-3):9-16. PubMed ID: 8901001
[TBL] [Abstract][Full Text] [Related]
7. Anticonvulsant activity of the NMDA antagonists, D(-)4-(3-phosphonopropyl) piperazine-2-carboxylic acid (D-CPP) and D(-)(E)-4-(3-phosphonoprop-2-enyl) piperazine-2-carboxylic acid (D-CPPene) in a rodent and a primate model of reflex epilepsy.
Patel S; Chapman AG; Graham JL; Meldrum BS; Frey P
Epilepsy Res; 1990; 7(1):3-10. PubMed ID: 2292244
[TBL] [Abstract][Full Text] [Related]
8. Excitatory amino acid antagonists, lamotrigine and BW 1003C87 as anticonvulsants in the genetically epilepsy-prone rat.
Smith SE; al-Zubaidy ZA; Chapman AG; Meldrum BS
Epilepsy Res; 1993 Jun; 15(2):101-11. PubMed ID: 8103738
[TBL] [Abstract][Full Text] [Related]
9. Potent oral anticonvulsant action of CPP and CPPene in DBA/2 mice.
Chapman AG; Graham J; Meldrum BS
Eur J Pharmacol; 1990 Mar; 178(1):97-9. PubMed ID: 2332032
[TBL] [Abstract][Full Text] [Related]
10. Tolerance to anticonvulsant effects of some benzodiazepines in genetically epilepsy prone rats.
De Sarro G; Di Paola ED; Aguglia U; de Sarro A
Pharmacol Biochem Behav; 1996 Sep; 55(1):39-48. PubMed ID: 8870036
[TBL] [Abstract][Full Text] [Related]
11. Effects of some AMPA receptor antagonists on the development of tolerance in epilepsy-prone rats and in pentylenetetrazole kindled rats.
De Sarro G; Di Paola ED; Gareri P; Gallelli L; Scotto G; De Sarro A
Eur J Pharmacol; 1999 Mar; 368(2-3):149-59. PubMed ID: 10193651
[TBL] [Abstract][Full Text] [Related]
12. Fenbufen pretreatment potentiates the anticonvulsant activity of CPPene and NBQX in DBA/2 mice.
De Sarro G; Renne S; Nava F; De Sarro A
J Pharm Pharmacol; 1994 Dec; 46(12):1017-22. PubMed ID: 7714713
[TBL] [Abstract][Full Text] [Related]
13. The gamma-aminobutyric acid uptake inhibitor, tiagabine, is anticonvulsant in two animal models of reflex epilepsy.
Smith SE; Parvez NS; Chapman AG; Meldrum BS
Eur J Pharmacol; 1995 Feb; 273(3):259-65. PubMed ID: 7737333
[TBL] [Abstract][Full Text] [Related]
14. Anticonvulsant activity of two orally active competitive N-methyl-D-aspartate antagonists, CGP 37849 and CGP 39551, against sound-induced seizures in DBA/2 mice and photically induced myoclonus in Papio papio.
Chapman AG; Graham JL; Patel S; Meldrum BS
Epilepsia; 1991; 32(4):578-87. PubMed ID: 1678345
[TBL] [Abstract][Full Text] [Related]
15. N6-cyclohexyladenosine and 3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid enhance the effect of antiepileptic drugs against induced seizures in mice.
Assi AA
J Pharm Pharm Sci; 2001; 4(1):42-51. PubMed ID: 11302789
[TBL] [Abstract][Full Text] [Related]
16. Electrical but not chemical kindling increases sensitivity to some phencyclidine-like behavioral effects induced by the competitive NMDA receptor antagonist D-CPPene in rats.
Wlaź P; Ebert U; Potschka H; Löscher W
Eur J Pharmacol; 1998 Jul; 353(2-3):177-89. PubMed ID: 9726648
[TBL] [Abstract][Full Text] [Related]
17. Repeated treatment with adenosine A1 receptor agonist and antagonist modifies the anticonvulsant properties of CPPene.
De Sarro G; Donato Di Paola E; Falconi U; Ferreri G; De Sarro A
Eur J Pharmacol; 1996 Dec; 317(2-3):239-45. PubMed ID: 8997606
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of CPP, a selective NMDA antagonist, in various rodent models of epilepsy. Comparison with other NMDA antagonists, and with diazepam and phenobarbital.
Löscher W; Nolting B; Hönack D
Eur J Pharmacol; 1988 Jul; 152(1-2):9-17. PubMed ID: 3061831
[TBL] [Abstract][Full Text] [Related]
19. Different effects of two N-methyl-D-aspartate receptor antagonists on seizures, spontaneous behavior, and motor performance in immature rats.
Mares P; Mikulecká A
Epilepsy Behav; 2009 Jan; 14(1):32-9. PubMed ID: 18786655
[TBL] [Abstract][Full Text] [Related]
20. Behavioural and neurochemical adaptations to nicotine in rats: influence of NMDA antagonists.
Shoaib M; Benwell ME; Akbar MT; Stolerman IP; Balfour DJ
Br J Pharmacol; 1994 Apr; 111(4):1073-80. PubMed ID: 8032593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
